Jingmin Zhou, Yamei Xu, Zhaofen Zheng, Shuyang Zhang, Jiefu Yang, Yuhui Zhang, Baopeng Tang, Huiyuan Han, Qing Zhang, Fan Liu, Wenhui Ding, Caizhen Qian, Guohai Su, Xiaohui Liu, Yuansheng Shen, Bei Shi, Xiangqing Kong, Zhiming Ge, Ping Zhang, Xiaomei Guo, Hong Zhang, Yuemin Sun, Yugang Dong, Guosheng Fu, Lei Feng, Junbo Ge
AIMS: A therapeutic strategy for chronic heart failure (HF) is to lower resting heart rate (HR). Ivabradine is a well-known HR-lowering agent, but limited prospective data exist regarding its use in Chinese patients. This study aimed to evaluate the effectiveness and safety of ivabradine in Chinese patients with chronic HF. METHODS AND RESULTS: This multicentre, single-arm, prospective, observational study enrolled Chinese patients with chronic HF. The primary outcome was change from baseline in HR at 1 and 6 months, measured by pulse counting...
January 9, 2024: ESC Heart Failure